Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan
The use of TNFαi for GIBD treatment has increased in Japan in recent years. Additional research is necessary to further evaluate TNFαi effectiveness in GIBD and other BD subtypes.
Authors
- Makoto Naganuma (ORCID: https://orcid.org/0000-0002-4244-3243)
- Tadakazu Hisamatsu (ORCID: https://orcid.org/0000-0002-1178-3536)
- Mitsuhiro Takeno (ORCID: https://orcid.org/0000-0002-9212-7046)
- Philippe Pinton (ORCID: https://orcid.org/0000-0002-4227-7687)
Institutions
- Kansai Medical University (JP)
- Kyorin University (JP)
- Nippon Medical School Musashi Kosugi Hospital (JP)
- Ferring Pharmaceuticals (Denmark) (DK)
Publication Details
- Journal
- Journal of Gastroenterology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1007/s00535-024-02191-y
- Citations
- 3
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- Ferring Pharmaceuticals